USDJPY stayed in a trading range between 110.84 and 114.73 for several weeks. The price action in the range is likely consolidation of the uptrend from 107.31. As long as 110.84 support holds, the upside movement could be expected to
January 7, 2018
Celgene (CELG) and Impact Biomedicines announced the signing of a definitive agreement in which Celgene will acquire Impact Biomedicines, which is developing fedratinib for myelofibrosis and polycythemia vera. Under the terms of the agreement, Celgene will pay approximately $1.1B upfront
AT40 = 67.5% of stocks are trading above their respective 40-day moving averages (DMAs)AT200 = 63.2% of stocks are trading above their respective 200DMAsVIX = 9.2Short-term Trading Call: cautiously bullish Commentary In my last Above the 40 I complained that
by Knowledge Wharton Wharton’s Barbara Kahn and Columbia’s Mark A. Cohen discuss the U.S. retail outlook for 2018. http://d1c25a6gwz7q5e.cloudfront.net/audio/20180103B-KWR-Kahn-Cohen.mp3 Initial market reports indicate the 2017 holiday season was a lucrative one for American retailers, with sales increasing 5% over the
Going into 2018 traders are feeling good; U.S markets continue to hit all-time highs; emerging markets have just had their best performing year since 2009; for some reason bitcoin continues to surge and even oil is up for the second year
The S&P broke upside from one channel to leave another. This is the third such acceleration in the last six months, leaving the index prone to a parabolic (if not profitable) run. Buying volume was low, but technical strength is
The economic calendar is about normal, with market participants back from holiday vacations (but perhaps fighting the snow). The key reports are the PPI and CPI. Inflation is the key 2018 worry for many, so these reports will get more
The biotech industry was on a comeback trail in 2017 after facing a number of challenges in 2016, including pricing pressure, rising competition, pipeline setbacks, slowdown in growth of mature products and generic competition for certain key drugs. Frequent FDA
This week will see a light news agenda, with the key items coming as key economic data releases for the U.S. Dollar at the end of the week. There is little else on the menu.It is a public holiday in
EUR/USD is now facing 1.2092 resistance. A breakout of this level will indicate that the uptrend from 1.0340 (Jan. 3 low) has resumed, then the next target would be at 1.2500 area. On the downside, a clear break below the
